Kimie Sai

Irinotecan pharmacokinetics/pharmacodynamics and UGT1A genetic polymorphisms in Japanese: roles of UGT1A1*6 and *28

Hironobu Minami, Kimie Sai, Mayumi Saeki et al. · Pharmacogenetics and Genomics · 2007 · 285 citations

The burden of diabetes and impaired glucose tolerance in India using the WHO 1999 criteria: prevalence of diabetes in India study (PODIS)

S.M. Sadikot, Aruna Nigam, Sidhartha Das et al. · Diabetes Research and Clinical Practice · 2004 · 199 citations

Nutrition, Metabolic Syndrome, Who 1999 +11

Haplotypes ofCYP3A4 and their close linkage withCYP3A5 haplotypes in a Japanese population

Hiromi Fukushima‐Uesaka, Yoshiro Saito, Hidemi Watanabe et al. · Human Mutation · 2003 · 165 citations

Haplotype analysis of ABCB1/MDR1 blocks in a Japanese population reveals genotype-dependent renal clearance of irinotecan

Kimie Sai, Nahoko Kaniwa, Masaya Itoda et al. · Pharmacogenetics · 2003 · 139 citations

Genetics, Haplotype Analysis, Genetic Epidemiology +16

Specific degradation of CRABP-II via cIAP1-mediated ubiquitylation induced by hybrid molecules that crosslink cIAP1 and the target protein

Keiichiro Okuhira, Nobumichi Ohoka, Kimie Sai et al. · FEBS Letters · 2011 · 114 citations